
                                SEQUENCE LISTING

<110> Mount Sinai School of Medicine of New York University
      Palese, Peter
      Garcia-Sastre, Adolfo
      Manicassamy, Balaji

<120> RECOMBINANT INFLUENZA VIRUSES AND USES THEREOF

<130> 6923-158-228

<140>
<141>

<150> 61/228,965          
<151> 2009-07-27  

<160> 36

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 1
Gly Ser Gly
 1          


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 2
Gly Ser Gly Gly Gly Ser Gly
 1               5          


<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 3
Gly Ser Gly Gly Gly Gly
 1               5      


<210> 4
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 4
Gly Ser Gly Gly Gly Gly Gly Ser Gly Gly Gly Gly Gly Ser Gly Gly
 1               5                  10                  15      
Gly Gly
        


<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 5
Gly Gly Gly Gly
 1              


<210> 6
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 6
Gly Gly Gly Gly Gly Gly Gly Gly
 1               5              


<210> 7
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 7
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
 1               5                  10                  15  


<210> 8
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 8
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
 1               5                  10                  15      
Gly Gly Gly Ser
            20  


<210> 9
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 9
Glu Ala Ala Lys
 1              


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 10
Glu Ala Ala Lys Glu Ala Ala Lys
 1               5              


<210> 11
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 11
Glu Ala Ala Lys Glu Ala Ala Lys Glu Ala Ala Lys
 1               5                  10          


<210> 12
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 12
Glu Ala Ala Lys Glu Ala Ala Lys Glu Ala Ala Lys Glu Ala Ala Lys
 1               5                  10                  15      


<210> 13
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 13
Glu Ala Ala Lys Glu Ala Ala Lys Glu Ala Ala Lys Glu Ala Ala Lys
 1               5                  10                  15      
Glu Ala Ala Lys
            20  


<210> 14
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 14
Gly Ser Gly Gly
 1              


<210> 15
<211> 38
<212> DNA
<213> Artificial Sequence

<220> 
<223> PTV-1 2A cleavage site

<400> 15
aagaaaaccc gggcccgatg gatccaaaca ctgtgtca                         38

<210> 16
<211> 41
<212> PRT
<213> Artificial Sequence

<220> 
<223> PTV-1 2A cleavage site

<400> 16
Ile Ala Phe Ala Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
 1               5                  10                  15      
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Asp Pro Asn Thr Val
            20                  25                  30          
Ser Ser Phe Gln Asp Ile Leu Leu Arg
        35                  40      


<210> 17
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> FDMV 2A cleavage site

<400> 17
Gln Leu Leu Asn Phe Asp Leu Leu Lys Leu Ala Gly Asp Val Glu Ser
 1               5                  10                  15      
Asn Pro Gly Pro
            20  


<210> 18
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Cardioviruses encephalomyocarditis virus EMCV cleavage site

<400> 18
His Tyr Ala Gly Tyr Phe Ala Asp Leu Leu Ile His Asp Ile Glu Thr
 1               5                  10                  15      
Asn Pro Gly Pro
            20  


<210> 19
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Equine rhinitis A virus ERAV cleavage site

<400> 19
Gln Cys Thr Asn Tyr Ala Leu Leu Lys Leu Ala Gly Asp Val Glu Ser
 1               5                  10                  15      
Asn Pro Gly Pro
            20  


<210> 20
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Porcine teschovirus PTV-1 cleavage site

<400> 20
Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn
 1               5                  10                  15      
Pro Gly Pro
            


<210> 21
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Drosophila C virus DrosC cleavage site

<400> 21
Ala Ala Arg Gln Met Leu Leu Leu Leu Ser Gly Asp Val Glu Thr Asn
 1               5                  10                  15      
Pro Gly Pro
            


<210> 22
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Thosea asigna virus TaV cleavage site

<400> 22
Arg Ala Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp Val Glu Glu
 1               5                  10                  15      
Asn Pro Gly Pro
            20  


<210> 23
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Infectious flacherie virus IFV cleavage site

<400> 23
Thr Arg Ala Glu Ile Glu Asp Glu Leu Ile Arg Ala Gly Ile Glu Ser
 1               5                  10                  15      
Asn Pro Gly Pro
            20  


<210> 24
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Trypanosoma cruzi AP endonuclease-like sequence cleavage site

<400> 24
Cys Asp Ala Gln Arg Gln Lys Leu Leu Leu Ser Gly Asp Ile Glu Gln
 1               5                  10                  15      
Asn Pro Gly Pro
            20  


<210> 25
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Foot-and-mouth disease virus P2A cleavage site 

<400> 25
Asn Phe Asp Leu Leu Lys Leu Ala Gly Asp Val Glu Ser Asn Pro Gly
 1               5                  10                  15      
Pro
    


<210> 26
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> caspase cleavage site 

<400> 26
Asp Glu Val Asp
 1              


<210> 27
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> caspase cleavage site 

<400> 27
Asp Asp Val Asp
 1              


<210> 28
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> caspase cleavage site 

<400> 28
Met Glu Leu Asp
 1              


<210> 29
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> caspase cleavage site 

<400> 29
Ala Glu Val Asp
 1              


<210> 30
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> caspase cleavage site 

<400> 30
Tyr Val His Asp
 1              


<210> 31
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> caspase cleavage site 

<400> 31
Asp Glu Glu Asp
 1              


<210> 32
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> caspase cleavage site 

<400> 32
Glu Ser Val Asp
 1              


<210> 33
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> ubiquitin-like protease cleavage site 

<400> 33
Leu Arg Gly Gly
 1              


<210> 34
<211> 15
<212> DNA
<213> Artificial Sequence

<220> 
<223> splice donor site for influenza virus A/Puerto Rico/8/34

<400> 34
ctttcaggta gattg                                                  15

<210> 35
<211> 41
<212> DNA
<213> Artificial Sequence

<220> 
<223> splice acceptor site for influenza virus A/Puerto Rico/8/34

<400> 35
caccattgcc ttctcttcca ggacatactg ctgaggatgt c                     41

<210> 36
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> 2A-like sequence

<220> 
<221> VARIANT        
<222> 2, 4
<223> Xaa = Any Amino Acid

<400> 36
Asp Xaa Glu Xaa Asn Pro Gly Pro
 1               5              
